WILLIAM STILWELL: Open Payments
NPI 1407102734 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 39 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $150 |
| Actelion Pharmaceuticals US, Inc. | 4 | $111 |
| Amgen Inc. | 6 | $84 |
| BridgeBio Pharma, Inc. | 5 | $73 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Novo Nordisk Inc | 2 | $35 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
Products named: LEQVIO, REPATHA, Attruby, UPTRAVI, Kerendia, OPSUMIT, JARDIANCE, VERQUVO.
Industry payments across NY — which companies pay providers there.
